Combined Treatment for Recurrent Herpetic Stromal Keratitis with Ulceration: a Case Report
DOI:
https://doi.org/10.31288/oftalmolzh201916164Keywords:
herpetic keratitis, treatmentAbstract
Herpes simplex keratitis (HSK) is a severe ophthalmic pathology which comprises 20-50% of inflammatory diseases in the cornea. Since keratitis is characterized by a long-term duration, severity, and a tendency to recurrence, studies on ophthalmic herpes and searches for new treatments are of great relevance.
Our clinical case demonstrated successful combined treatment of a recurrent stromal herpetic corneal lesion with ulceration. Both treatments, conservative (complex etiotropic, anti-viral, anti-inflammatory, and nutrition-improving) and surgical (an onlay technique), were successful. At 12 months after surgery, the patients had no pain syndrome; the corneal surface was epithelialized. No recurrence of herpetic keratitis was observed.
Thus, a combination of etiotropic pathogenic treatment and AM transplantation appears to be effective for severe long-lasting recurrent herpetic keratitis with the presence of defects on the corneal surface.
References
1.Anina EI, Martoplyas KV. [Corneal Pathology among adult population in Ukraine]. [Proceedings of XII Ukrainian Congress of Ophthalmologists, 26-28 May 2010]. Odessa; 2010:5. Russian.
2.Kasparov AA. [Treatment of Herpes virus keratitis: 35 year experience]. [New technologies in treatment of corneal diseases: All-Russian Scientific Practical Conference with international participations, Fedorov Memorial Lectures, 25-26 June 2004: collection of papers]. M.;2004: 574-80. Russian.
3.Dembskii LK, Shirshova ON, Mironiuk OV. [Some aspects of organization of virus keratitis treatment]. [Surgical treatment and rehabilitation of patients with ophthalmic pathology: scientific and practical conference with international participation, 2004: proceedings]. K.; 2004: 99-100. Russian.
4.Kasparov AA. [Treatment of herpes virus keratitis. In: Current issues of herpes virus infections]. M.; 2004: 31-7. Russian.
5.Kasparov AA. [Modern methods for herpes virus keratitis]. [Scientific and Practical conference "Modern methods of diagnostics and treatment for cornea and sclera diseases"]. M.;2007:273-6. Russian. Современные методы лечения герпесвирусного кератита // Научно-практич.
6.Kaye S, Choudhary A. Herpes simplex keratitis. Progress in retinal and eye research. 2006;25(4):355 - 380. https://doi.org/10.1016/j.preteyeres.2006.05.001
7.Kovalchuk LV, Gankovskaya LV, Martirosova NI, Vasilenkova LV, Sokolova EV, Levchenko VA. [The approaches to immunocorrecting therapy in ophthalmology on position of new presentation about inherent immunity] Refraktsionnaia khirurgiia I oftalmologiia. 2008;1:44-8. Russian.
8.Pozdnyakov VI, Maichuk YuF, Pozdnyakova VV. [Algorithm of a therapy for severe ophthalmic herpes]. [Current issues of inflammatory eye diseases: scientific and practical conference, 20-21 November, 2001: proceedings]. M.;2001:151-3. Russian.
9.Kasparov AA. [Modern methods of treatment for severe infectious diseases of the cornea]. [IX Congress of Ophthalmologists of Russia, 16-18 June 2010: proceedings]. M.; 2010:296-8. Russian.
10.Gaydamaka TB. [Antirelapse treatment of the patients with herpetic keratites]. Oftalmol Zh. 2009;5:6-9. Russian.
11.Sereda EV, Drozhzhina GI, Gaidamaka TB, Ivanovskaia EV, Ostashevskii VL, Ivanova ON, Kogan BM. [Efficacy of different amniotic membrane transplantation techniques in patients with inflammatory and degenerative pathology of the cornea]. Oftalmol Zh. 2016;4:3-10. Russian.
12.Kim JC, Tseng SC. Transplantation of preserved human amniotic membrane for surface reconstruction in severely damaged rabbit corneas. Cornea. 1995;14:473-84.https://doi.org/10.1097/00003226-199509000-00006
13.Trufanov SV. [The use of preserved human amniotic membrane in reconstructive surgery of the eye]. Author's thesis for Cand. Med. Sc. M.:2004. 24p. Russian.
14.Fedorova EA. [The use of lyophilized amniotic membrane in treatment of inflammatory corneal diseases]. Author's thesis for Cand. Med. Sc. M.:2004. 24p. Russian.
15.Seitz B. Amniotic membrane transplantation. An indispensable therapy option for persistent corneal epithelial defects. Ophthalmologe. 2007;104:1075-9.
16.Shortt AJ, Secker GA, Notara MD et al. Transplantation of ex vivo cultured limbal epithelial stem cells: a review of techniques and clinical results. Surv Ophthalmol. 2007;52:483-502.https://doi.org/10.1016/j.survophthal.2007.06.013
17.Koizumi NJ, Inatomi TJ, Sotozono CJ, Fullwood NJ, Quantock AJ, Kinoshita S. Growth factor mRNA and protein in preserved human amniotic membrane. Curr Eye Res. 2000;20:173-7.https://doi.org/10.1076/0271-3683(200003)2031-9FT173
18.Tseng SC, Espana EM, Kawakita T et al. How does amniotic membrane work? Ocul Surf. 2004;2:177-87.https://doi.org/10.1016/S1542-0124(12)70059-9
19.Sippel KC, Ma JJ, Foster CS. Amniotic membrane surgery. Curr Opin Ophthalmol. 2001;12:269-81.https://doi.org/10.1097/00055735-200108000-00006
20.Ueta M, Kweon MN, Sano Y et al. Immunosuppressive properties of human amniotic membrane for mixed lymphocyte reaction. Clinical and Experimental Immunology. 2002;129:464-70.https://doi.org/10.1046/j.1365-2249.2002.01945.x
21.Kheirkhah A, Johnson DA, Paranjpe DR, Raju VK, Casas V, Tseng SC. Temporary sutureless amniotic membrane patch for acute alkaline burns. Arch Ophthalmol. 2008;126:1059-66.https://doi.org/10.1001/archopht.126.8.1059
22.Thomasen H, Pauklin M, Steuhl KP, Meller D. Comparison of cryopreserved and air-dried human amniotic membrane for ophthalmologic applications. Graefes Arch Clin Exp Ophthalmol. 2009;247:1691-700.https://doi.org/10.1007/s00417-009-1162-y
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Л. Ф. Тройченко, Т. Б. Гайдамака, Г. И. Дрожжина
This work is licensed under a Creative Commons Attribution 4.0 International License.
This work is licensed under a Creative Commons Attribution 4.0 International (CC BY 4.0) that allows users to read, download, copy, distribute, print, search, or link to the full texts of the articles, or use them for any other lawful purpose, without asking prior permission from the publisher or the author as long as they cite the source.
COPYRIGHT NOTICE
Authors who publish in this journal agree to the following terms:
- Authors hold copyright immediately after publication of their works and retain publishing rights without any restrictions.
- The copyright commencement date complies the publication date of the issue, where the article is included in.
DEPOSIT POLICY
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) during the editorial process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work with an acknowledgement of its initial publication in this journal.
- Post-print (post-refereeing manuscript version) and publisher's PDF-version self-archiving is allowed.
- Archiving the pre-print (pre-refereeing manuscript version) not allowed.
